Biomarker ID | 551 |
PMID | 20973404 |
Year | 2010 |
Biomarker | Total sialic acid |
Biomarker Basis | Concentration Based (mg/dL) |
Biomolecule | Metabolites |
Source | Serum |
Subjects | Humans |
Regulation | Upregulated (mg/dL): (Controls: 6.25±3.49) Vs (Prostate Cancer: 15.1±4.83) |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways Include: Organic anion transporters,Amino acid and oligopeptide SLC transporters, Transport of inorganic cations/anions and amino acids/oligopeptides,Lysosome, SLC-mediated transmembrane transport |
Experiment | Control Vs Cancer |
Type of Biomarker | Diagnostic |
Cohort | 50 patients as controls, 75 with BPH and 100 with Prostate Cancer were chosen for the study |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p<0.001 |
Method Used | ELISA |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | SLC17A5 |